Dominic Smethurst Insider Profile
4 Followers
Dominic Smethurst, CMO at Corbus Pharmaceuticals, holds 89.79K shares in Corbus Pharmaceuticals (Ticker: CRBP), holds 36.70K shares in Bicycle Therapeutics (Ticker: BCYC). Most recently, Dominic Smethurst Sold ― shares of Corbus Pharmaceuticals on Mar 04, 2026 for an estimated value of $50.54K.
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+32.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dominic Smethurst holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dominic Smethurst
Dominic Smethurst's Trading History
Corbus Pharmaceuticals
Mar 04, 2026
CMO
Informative Sell
50.54K
$378.91K
Bicycle Therapeutics
Jan 05, 2023
CMO
Uninformative Buy
―
$134.32K
List of latest transactions for each holding click on a transaction to see Dominic Smethurst's performance on stock
You May Also Like
Dominic Smethurst insider profile FAQ
What is the percentage of profitable transactions made by Dominic Smethurst?
The percentage of profitable transactions made by Dominic Smethurst is 75%.
What is the average return per transaction made by Dominic Smethurst?
The average return per transaction made by Dominic Smethurst is 32.10%.
What stocks does Dominic Smethurst hold?
Dominic Smethurst holds: CRBP, BCYC stocks.
What was Dominic Smethurst’s latest transaction?
Dominic Smethurst latest transaction was an Informative Sell of $50.54K.
What was Dominic Smethurst's most profitable transaction?
Dominic Smethurst’s most profitable transaction was an Informative Sell of CRBP stock on March 4, 2026. The return on the trade was 51.90%.
What is Dominic Smethurst's role in Corbus Pharmaceuticals?
Dominic Smethurst's role in Corbus Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.